Mahon Paul A

United Therapeutics Corp · EVP & GENERAL COUNSEL

Mahon Paul A is listed in filings as EVP & GENERAL COUNSEL at United Therapeutics Corp. This profile follows SEC Form 4 activity through Jun 4, 2026, including sale activity. Recent filings connect the profile to United Therapeutics Corp (UTHR). The current snapshot covers public activity from May 21, 2026 to Jun 4, 2026. Reported amounts are shown as $1.4M to $812.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceCurrent Price
United Therapeutics CorpUTHR$1M2.2k sharesSellMay 21, 2026$561.99$535.83
United Therapeutics CorpUTHR$1M2k sharesSellMay 21, 2026$564.06$535.83
United Therapeutics CorpUTHR$746k1.3k sharesSellMay 21, 2026$562.93$535.83
United Therapeutics CorpUTHR$707k1.3k sharesSellMay 21, 2026$565.20$535.83
United Therapeutics CorpUTHR$357k640 sharesSellMay 21, 2026$557.85$535.83
United Therapeutics CorpUTHR$169k300 sharesSellMay 21, 2026$562.50$535.83
United Therapeutics CorpUTHR$153k270 sharesSellMay 21, 2026$566.05$535.83
United Therapeutics CorpUTHR$112k200 sharesSellMay 21, 2026$559.99$535.83
United Therapeutics CorpUTHR$61k110 sharesSellMay 21, 2026$555.72$535.83
United Therapeutics CorpUTHR$5.6k10 sharesSellMay 21, 2026$556.70$535.83